Koshinski Asset Management’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $276K | Sell |
|
|||||
|
2021
Q4 | $372K | Buy |
|
|||||
|
2021
Q3 | $426K | Buy |
|
|||||
|
2021
Q2 | $438K | Sell |
|
|||||
|
2021
Q1 | $383K | Sell |
|
|||||
|
2020
Q4 | $405K | Sell |
|
|||||
|
2020
Q3 | $388 | Sell |
|
|||||
|
2020
Q2 | $362K | Sell |
|
|||||
|
2020
Q1 | $257K | Hold |
|
|||||
|
2019
Q4 | $340K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $263K | Buy |
|
|||||
|
2019
Q1 | $254 | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $372K | Buy |
|
|||||
|
2018
Q2 | $224K | Sell |
|
|||||
|
2018
Q1 | $222K | Sell |
|
|||||
|
2017
Q4 | $288K | Sell |
|
|||||
|
2017
Q3 | $433K | Buy |
|
|||||
|
2017
Q2 | $366K | Hold |
|
|||||
|
2017
Q1 | $331K | Buy |
|
|||||
|
2016
Q4 | $272K | Sell |
|
|||||
|
2016
Q3 | $349K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $301K | Buy |
|
|||||
|
2015
Q3 | $363K | Sell |
|
|||||
|
2015
Q2 | $454K | Buy |
|
|||||
|
2015
Q1 | $396K | Buy |
|
|||||
|
2014
Q4 | $313K | Buy |
|